Novartis
NVS
1,400 hedge funds and large institutions have $17.2B invested in Novartis in 2025 Q3 according to their latest regulatory filings, with 115 funds opening new positions, 476 increasing their positions, 481 reducing their positions, and 74 closing their positions.
55% more first-time investments, than exits
New positions opened: 115 | Existing positions closed: 74
6% more capital invested
Capital invested by funds: $16.2B → $17.2B (+$990M)
1% more funds holding
Funds holding: 1,383 → 1,400 (+17)
0.02% more ownership
Funds ownership: 6.32% → 6.34% (+0.02%)
1% less repeat investments, than reductions
Existing positions increased: 476 | Existing positions reduced: 481
34% less call options, than puts
Call options by funds: $261M | Put options by funds: $398M
35% less funds holding in top 10
Funds holding in top 10: 17 → 11 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$268M |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
+$88M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$58.6M |
| 4 |
Goldman Sachs
New York
|
+$49.8M |
| 5 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$38.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$134M |
| 2 |
Primecap Management
Pasadena,
California
|
-$129M |
| 3 |
Millennium Management
New York
|
-$101M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$91.1M |
| 5 |
Renaissance Technologies
New York
|
-$51.3M |
NVS Hedge Fund Activity: Q3 2025 in Review
1,400 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q3 2025, worth a combined $17.2B — up 6.1% from $16.2B a quarter earlier.
Buyers outnumbered sellers: 115 funds opened new NVS positions and 74 closed out — a net gain of 41 holders — while 476 added to existing stakes and 481 trimmed.
The largest buyer was GQG Partners, adding an estimated $268M. The largest seller was Wellington Management Group, cutting an estimated $134M.
- 1,400 institutional investors held Novartis (NVS) as of Q3 2025, up from 1,383 in Q2 2025.
- Funds reported $17.2B of Novartis stock for Q3 2025, up 6.1% quarter-over-quarter.
- 115 funds opened new Novartis positions in Q3 2025 and 74 closed out, a net change of +41 holders.
- The largest Novartis buyer in Q3 2025 was GQG Partners, an estimated $268M added.
- The largest Novartis seller in Q3 2025 was Wellington Management Group, an estimated $134M sold.
Based on aggregated 13F filings for Q3 2025.